Board

As a venture capitalist and practicing physician, Stephen Bloch, brings his medical knowledge and investment expertise to the DICOM Grid board of directors. Bloch is a general partner at Canaan Partners, a funder of high-tech healthcare companies. Before joining Canaan Partners in 2002, Bloch helped start several cutting-edge medical companies, including OmniSonics Medical Technologies, Radiology Management Sciences (RMS), and TeleRad.

Bloch also sits on the board of Amicus Therapeutics and is the director of Advanced BioHealing, Cylex, and Liquidia.

Bloch started his career as a radiologist after receiving his medical degree from the University of Rochester. He also holds a Master of Arts from Harvard University in the history of science and public policy.

Dr. Myles Greenberg is a partner at CHL Medical Partners, a venture capital firm specializing in biotechnology, molecular diagnostic, healthcare service, and medical device companies. Prior to joining CHL Medical Partners, Greenberg was a senior principal at Pappas Ventures, leading six major investments. He has also served as the assistant clinical director at the Department of Emergency Medicine at Beth Israel Deaconess Medical Center and helped with the merger of Beth Israel and Deaconess Hospital Emergency Departments.

Greenberg is also on the board of directors of Millennium Pharmacy Systems, Oriel Therapeutics, ParinGenix, Still River Systems, and Vertos Medical.

Greenberg graduated from the University of Pennsylvania School of Engineering and Applied Science, Yale University School of Medicine, and holds a Master of Business Administration from Harvard University.

Morris Panner, DICOM Grid's CEO, is an experienced software executive, having recently built and sold an industry-leading business process software company, OpenAir, Inc., to Larry Ellison’s on-demand software company, NetSuite (NYSE:N). Morris built the company from inception to a global company with Fortune 500 clients. Previously, Mr. Panner had worked in healthcare IT, partnering to form an early teleradiology venture.

Morris also has worked as a Federal Prosecutor for the U.S. Department of Justice and as a corporate attorney with Wachtell, Lipton, where, among other things, he represented major pharmaceutical companies.

Morris is on the Board and a past Chairperson of the software board of the Software and Information Industry Association; served as a Senior Advisor on Cyber-Security at the Harvard Kennedy School’s Belfer Center; as well as the board of Drug Strategies, a not-for-profit dedicated to fighting addiction and drug abuse. He has been featured in the “Boss Column” of the New York Times and in Fortune, Business Week and other leading publications. Morris has a BA from Yale University and a JD from Harvard University.

Dr. Stephen M. Papadopoulos is a practicing neurosurgeon and the director of clinical operations at Barrow Neurological Institute. He has been working in the field of surgical navigation for more than 15 years and is considered a pioneer in computer-assisted neurosurgery. While at the University of Michigan, Papadopoulos helped develop their revolutionary image-guided surgery program.

Papadopoulos is a graduate of the University of Texas and University of Michigan medical schools. He is a clinical professor at the University of Arizona and a past president of the Congress of Neurological Surgeons.

Mike V. Wall, formerly DICOM Grid’s CEO, continues on its board of directors. Mike was the general manager of Intel Corporation’s Storage Group, based in Chandler, Arizona, where he was responsible for managing all aspects of Intel’s $500M storage business. Previous assignments included general manager of Intel’s Supercomputer Systems Division. His division led the introduction of the Intel architecture into the high performance computing market with massively parallel systems and achieved revenues of $100M. Prior to joining Intel Corporation in 1992, Mike was general manager at Cray Research, and was responsible for North American Operations. He also held several marketing management positions at IBM in New York City. He has a strong background in technology start-ups and marketing. Wall started Wall Technology Advisors, a consultant group working with new high-tech companies. He currently sits on the boards of DICOM Grid, Atempo, and Nirvanix.

Wall holds a Master of Management Sciences from Averill Harriman College for Urban and Policy Sciences at SUNY Stony Brook. In addition, he graduated from Stony Brook University with a Bachelor of Arts in economics.

Steven Yecies is the founder and CEO of Chronic Health Capital. He has over 20 years of experience as an investor, consultant and executive in building successful, innovative health care information technology and health care service delivery companies. He was the founder and general manager of Scient’s global health and wellness business where he built a number of the leading first generation e-health businesses. His experience in the diagnostic imaging space includes having run a radiology benefits management company and having built internet enabled imaging data warehouses for government health systems.

Mr. Yecies earned an MBA degree from Harvard Business School, a JD degree from the University of California at Berkeley, and an AB degree in Government from Dartmouth College.